ClinicalTrialsFinder

Diffuse Large B Cell Lymphoma Clinical Trials in Gdynia, Pomeranian Voivodeship

1 recruitingGdynia, Pomeranian Voivodeship, Poland

Showing 1–1 of 1 trials

Recruiting
Phase 2Phase 3

A Study of Zilovertamab Vedotin (MK-2140) in Combination With Standard of Care in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (rrDLBCL) (MK-2140-003)

Diffuse Large B Cell LymphomaDLBCL
Merck Sharp & Dohme LLC290 enrolled116 locationsNCT05139017